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Abstract
We describe a 22-year old female who presented with a 5-year history of a palpable, painless mass in
the right flank. Computerized tomography demonstrated a solid renal mass measuring 18 cm ×  13 cm with
peripheral calcification, areas of vascularity and necrosis. The appearance suggested renal cell carcinoma or
nephroblastoma, but percutaneous renal biopsy suggested an adrenal origin. At right radical nephrectomy,
the adrenal gland was completely normal. Histology showed sheets and nests of epithelioid cells with
abundant eosinophilic to clear cytoplasm, confirming a diagnosis of epithelioid angiomyolipoma (EAML),
a rare mesenchymal tumor belonging to the perivascular epithelioid cell tumor family (PEComas). At 33
months followup, there was no evidence of recurrence or metastases.
© 2014 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. 
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Perivascular epithelioid cell tumors (PEComas) represent a small
family of rare tumors, which includes both classic angiomyolipoma
Abbreviations: PEComa, perivascular epithelioid cell tumor; EAML,
epithelioid angiomyolipoma; AML, angiomyolipoma; RCC, renal cell carci-
Open access under CC BY-Nnoma; CT, computerized topography; IVC, inferior vena cava; TSC, tuberous
sclerosis complex.
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http://dx.doi.org/10.1016/j.afju.2014.07.002AML) and its potentially malignant variant epithelioid angiomy-
lipoma (EAML). PEComas are associated with the tuberous
clerosis complex and characterized by the World Health Organi-
ation as a “proliferation of perivascular epithelioid cells (PECs)”
1]. EAML is often confused with renal cell carcinoma (RCC) given
imilar presenting symptoms and lack of macroscopic fat on radio-
raphic imaging [2]. Herein, we report a case of renal epithelioid
ngiomyolipoma.
 license.ase report
 22-year old female was referred to our facility from an outside
nstitution with a 5-year history of being aware of a palpable mass in
d hosting by Elsevier B.V.   Open access under CC BY-NC-ND license.
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Figure  1  (A) Non-contrasted CT showing solid mass in right flank
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Eith linear peripheral calcification. (B) Contrast-enhanced CT (arterial
hase) showing areas of necrosis in tumor arising from right kidney.
he right upper quadrant of her abdomen. She denied any associated
ymptoms, including pain, hematuria or weight loss. Her past med-
cal history was unremarkable, specifically no history of epilepsy or
ental retardation, and there was no family history of renal malig-
ancy or tuberous sclerosis. On physical examination, there were no
utaneous or other stigmata of tuberous sclerosis. A large (>10 cm)
on-tender, mobile mass was palpable in her right upper quadrant.
aboratory results demonstrated normal hemoglobin (13.3 g/dl) and
reatinine (40 mol/l), as well as a negative urinalysis. Electrolytes
ere within normal range, and she was non-reactive on HIV testing.
omputerized topography (CT) of the abdomen with intravenous
ontrast identified an 18 cm ×  13 cm mass with linear peripheral
alcification, areas of vascularity and necrosis, arising from the right
idney, which contained a few small cysts (Fig. 1A and B). No
isceral metastases or involvement of the right renal vein or IVC
ere noted. Chest X-ray was normal.
he patient underwent a percutaneous right renal biopsy to deter-
ine whether the renal mass was a Wilms’ tumor (nephroblastoma),
hich could be treated with chemotherapy prior to surgery. The his-
ology showed cells with predominantly clear cell cytoplasm, and
ome cells with eosinophilic/granular cytoplasm. It was positive for
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elan A on immunohistochemistry. Diagnosis was made of “a clear-
ell lesion most likely of adrenal origin”. Further endocrine studies
evealed a normal serum cortisol (193 nmol/l) and normal 24-h urine
ortisol (487 nmol/24 h), as well as normal urine metanephrines
metadrenaline/metnoradrenaline at 118/165 nmol/L).
he was scheduled for a radical right nephrectomy and adrenalec-
omy. Intraoperatively, the right adrenal was found to be uninvolved,
s the tumor grossly originated solely from the right kidney. It
as noted to be well encapsulated and mobile. The right adrenal
as normal and was not removed. The postoperative course was
ncomplicated, and she was discharged on post-surgical day 5.
acroscopically, the mass was solid, tan in color and measured
7.9 cm ×  19 cm ×  12 cm with a weight of 2000 g. It was situated in
he pelvis of the kidney and bulging into the surrounding soft tissue.
ysts were noted along the periphery.
icroscopically, different growth patterns were encountered includ-
ng solid sheets, nests and papillary structures. The tumor cells were
pithelioid with abundant eosinophilic to clear cytoplasm (Fig. 2A).
ncipient tumor necrosis was noted (<10%). One mitotic figure
r less per 50 high power fields was identified. Invasion into the
enal parenchyma was evident but lymphovascular invasion was not
emonstrated. The peripheral tumor free margin was less than 1 mm.
mmunohistochemically, the tumor cells stained strongly positive
or Melan A and HMB-45 (Fig. 2B and C). Smooth muscle actin
as focally positive. CD-10, S100, and chromogranin staining were
egative. Final diagnosis was pure epithelioid angiomyolipoma.
he patient was seen in follow-up at 33 months after surgery. She
as asymptomatic, and on examination and CT imaging there was
o evidence of local tumor recurrence or metastases.
iscussion
enal epithelioid angiomyolipoma (EAML) is a rare mesenchymal
umor belonging to the perivascular epithelioid cell tumor family
PEComas) [1,2]. Other PEComa members include pulmonary and
xtrapulmonary clear cell “sugar” tumors, lymphangiomyomatosis,
nd clear cell myomelanotic tumors of the falciform ligament, liga-
entum teres, and common bile duct [3]. EAML is closely related
o the classical, triphasic angiomyolipoma (AML), and also demon-
trates loss of the 16p chromosome and tumor suppressor gene TSC2
16p13) [4]. Both tumors are strongly associated with the tuberous
clerosis complex (TSC).
nlike its typically benign counterpart, EAML has well docu-
ented malignant potential with approximately one third of reported
ases developing metastatic disease [1,3–6]. Tumor suppressor p53
TP53) mutation is detected in epithelioid, but not classic AML,
uggesting that it may play a role in malignant transformation [1].
hile both neoplasms have a strong association with TSC, a nearly
-fold greater prevalence of TSC has been demonstrated amongst
AML patients [7].hile its triphasic pattern easily identifies AML, pure EAML
s typically devoid of microscopic fat and abnormal vessels [8].
istologically, it appears as a proliferation of epithelioid cells
ith abundant granular cytoplasm. The tumor cells are round to
Renal epithelioid angiomyolipoma presenting as renal cell carcinoma 
Figure  2  (A) Photomicrograph showing sheets and nests of epithe-
lioid cells, many with abundant eosinophilic cytoplasm and some with
clear cytoplasm (hematoxylin and eosin stain 200×). (B) Melan A
immunohistochemical stain showing cytoplasmic positivity in many
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Rtumor cells. (C) HMB 45 immunohistochemical stain displaying posi-
tivity in the cytoplasm of tumor cells.
polygonal with enlarged vesicular nuclei and prominent nucleoli
[1]. Giant multinucleated cells and hemorrhage are common [3].EAML is often confused with RCC, especially on contrasted radio-
graphic studies as it appears as an enhancing mass without a visible
adipose component [2]. The frequent presence of necrosis, infil-
trative growth, and extension into the inferior vena cava/renal vein199
ypically results in a RCC diagnosis, metastatic evaluation, and rad-
cal nephrectomy [9]. On histology, it may also be misdiagnosed
s RCC, sarcoma, or medullary carcinoma based upon its dominant
pithelioid appearance [5]. Accurate diagnosis requires immuno-
istochemical analysis. EAML expresses typical AML staining
atterns with positive HMB-45, smooth muscle actin, Melan A,
nd occasionally CD68 [10]. In contrast, RCC demonstrates immu-
ostaining positive for cytokeratin (CK) and epithelial membrane
ntigen (EMA) [2].
nitial management of EAML consists of surgical excision. There is
o standard algorithm for long term surveillance following surgical
ure, however, it is highly recommended, as disease recurrence has
een documented more than 5 years after surgical excision [11].
leeker et al. recently introduced a modified Folpe criteria for the
isk stratification of PEComas [12]. Tumors defined as ‘malignant’
xhibit two or more of the following features: size >5 cm, infiltrative
rowth pattern, high nuclear grade and cellularity, mitotic rate >1/50
PG, necrosis, or vascular invasion.
or disease recurrence and metastasis, recent studies have demon-
trated success with mTOR inhibitors [6,13,14]. This therapy targets
he mTOR cell signaling pathway involved in RNA translation,
 member of which includes the TSC2 gene product tuberin
4].
ur patient’s tumor was risk classified as ‘malignant’ secondary to
ts high nuclear grade, large size, and presence of necrosis. How-
ver, her preoperative metastatic evaluation was negative. She was
een at our clinic at 33 months postoperatively without evidence of
ecurrence, but has subsequently been lost to follow up.
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